Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176812541> ?p ?o ?g. }
- W3176812541 endingPage "1213" @default.
- W3176812541 startingPage "1203" @default.
- W3176812541 abstract "Sarcopenia is a known risk factor for poor outcomes across many chronic diseases. The impact on outcomes of both pre-existing sarcopenia and acute muscle wasting (AMW) in acute critical illness caused by sepsis remain unclear.We conducted a prospective longitudinal cohort study of critically ill patients with intra-abdominal sepsis utilizing abdominal computed tomography at sepsis onset to determine baseline skeletal muscle index (SMI). Biomarkers of inflammation and catabolism were measured through 28 days while hospitalized. We performed follow-up evaluations of strength and physical function at 3, 6, and 12 months, with interval CT analyses at 3 and 12 months to evaluate changes in muscle mass. Measured clinical outcomes included development of chronic critical illness (≥14 days in intensive care with persistent organ dysfunction), long-term functional status, and 1 year mortality.Among 47 sepsis patients enrolled (mean age 53 ± 14 years), half (n = 23; 49%) were sarcopenic at baseline. Overall, sepsis patients exhibited acute and persistent muscle wasting with an average 8% decrease in SMI from baseline at 3 months (P = 0.0008). Sarcopenic (SAR) and non-sarcopenic (NSAR) groups were similar in regards to age and comorbidity burden. SAR patients had greater acute physiologic derangement (APACHE II, 18 vs. 12.5), higher incidence of multiple organ failure (57% vs. 17%), longer hospital (21 vs. 12 days) and intensive care unit length of stays (13 vs. 4 days), and higher inpatient mortality (17% vs. 0%; all P < 0.05). Pre-existing SAR was a strong independent predictor of early death or developing chronic critical illness (odds ratio 11.87, 95% confidence interval CI 1.88-74.9; P = 0.009, area under the curve 0.880) and was associated with significantly higher risk of 1-year mortality (34.9% vs. 4.2%, p = 0.007). Lower baseline SMI was also predictive of poor functional status at 12 months (OR 0.89, 95% confidence interval 0.80-0.99; p = 0.039, area under the curve 0.867). Additionally, SAR patients had AMW with persistent muscle mass loss at 3 months that was associated with decreased health-related quality of life and SF-36 physical function domains (P < 0.05). Persistent AMW at 3 months was not predictive of mortality or poor functional status, with return to near-baseline muscle mass among sepsis survivors by 6 months.Critically ill patients have an acute and persistent loss of muscle mass after intra-abdominal sepsis, which is associated with decreased health-related quality of life and physical function at 3 months. However, pre-existing sarcopenia, rather than persistent acute muscle mass loss at 3 months after sepsis, is independently associated with poor long-term functional status and increased 1 year mortality." @default.
- W3176812541 created "2021-07-05" @default.
- W3176812541 creator A5013215682 @default.
- W3176812541 creator A5015888087 @default.
- W3176812541 creator A5019225342 @default.
- W3176812541 creator A5024265075 @default.
- W3176812541 creator A5027562579 @default.
- W3176812541 creator A5027929010 @default.
- W3176812541 creator A5031214939 @default.
- W3176812541 creator A5033552715 @default.
- W3176812541 creator A5040353507 @default.
- W3176812541 creator A5059428223 @default.
- W3176812541 creator A5065572700 @default.
- W3176812541 creator A5081543510 @default.
- W3176812541 creator A5090126800 @default.
- W3176812541 date "2021-06-30" @default.
- W3176812541 modified "2023-10-18" @default.
- W3176812541 title "The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis" @default.
- W3176812541 cites W1767128030 @default.
- W3176812541 cites W1918799129 @default.
- W3176812541 cites W1980424395 @default.
- W3176812541 cites W1996746689 @default.
- W3176812541 cites W2000445173 @default.
- W3176812541 cites W2014053695 @default.
- W3176812541 cites W2021632178 @default.
- W3176812541 cites W2037048755 @default.
- W3176812541 cites W2048977247 @default.
- W3176812541 cites W2051075414 @default.
- W3176812541 cites W2076668534 @default.
- W3176812541 cites W2082976102 @default.
- W3176812541 cites W2097022747 @default.
- W3176812541 cites W2098503599 @default.
- W3176812541 cites W2102902846 @default.
- W3176812541 cites W2103520707 @default.
- W3176812541 cites W2107089530 @default.
- W3176812541 cites W2118240638 @default.
- W3176812541 cites W2125311701 @default.
- W3176812541 cites W2127424726 @default.
- W3176812541 cites W2135646847 @default.
- W3176812541 cites W2144586749 @default.
- W3176812541 cites W2145796234 @default.
- W3176812541 cites W2145925103 @default.
- W3176812541 cites W2171267283 @default.
- W3176812541 cites W2313339984 @default.
- W3176812541 cites W2326471898 @default.
- W3176812541 cites W2466868774 @default.
- W3176812541 cites W2571595080 @default.
- W3176812541 cites W2593515375 @default.
- W3176812541 cites W2741510240 @default.
- W3176812541 cites W2774937159 @default.
- W3176812541 cites W2783031572 @default.
- W3176812541 cites W2785297623 @default.
- W3176812541 cites W2805483060 @default.
- W3176812541 cites W2897513125 @default.
- W3176812541 cites W2912078366 @default.
- W3176812541 cites W2965857027 @default.
- W3176812541 cites W2982669953 @default.
- W3176812541 cites W3176812541 @default.
- W3176812541 doi "https://doi.org/10.1002/jcsm.12752" @default.
- W3176812541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8517344" @default.
- W3176812541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34196134" @default.
- W3176812541 hasPublicationYear "2021" @default.
- W3176812541 type Work @default.
- W3176812541 sameAs 3176812541 @default.
- W3176812541 citedByCount "30" @default.
- W3176812541 countsByYear W31768125412021 @default.
- W3176812541 countsByYear W31768125412022 @default.
- W3176812541 countsByYear W31768125412023 @default.
- W3176812541 crossrefType "journal-article" @default.
- W3176812541 hasAuthorship W3176812541A5013215682 @default.
- W3176812541 hasAuthorship W3176812541A5015888087 @default.
- W3176812541 hasAuthorship W3176812541A5019225342 @default.
- W3176812541 hasAuthorship W3176812541A5024265075 @default.
- W3176812541 hasAuthorship W3176812541A5027562579 @default.
- W3176812541 hasAuthorship W3176812541A5027929010 @default.
- W3176812541 hasAuthorship W3176812541A5031214939 @default.
- W3176812541 hasAuthorship W3176812541A5033552715 @default.
- W3176812541 hasAuthorship W3176812541A5040353507 @default.
- W3176812541 hasAuthorship W3176812541A5059428223 @default.
- W3176812541 hasAuthorship W3176812541A5065572700 @default.
- W3176812541 hasAuthorship W3176812541A5081543510 @default.
- W3176812541 hasAuthorship W3176812541A5090126800 @default.
- W3176812541 hasBestOaLocation W31768125411 @default.
- W3176812541 hasConcept C126322002 @default.
- W3176812541 hasConcept C177713679 @default.
- W3176812541 hasConcept C188816634 @default.
- W3176812541 hasConcept C2776214593 @default.
- W3176812541 hasConcept C2776376669 @default.
- W3176812541 hasConcept C2778384902 @default.
- W3176812541 hasConcept C2779159551 @default.
- W3176812541 hasConcept C2779764123 @default.
- W3176812541 hasConcept C2987404301 @default.
- W3176812541 hasConcept C71924100 @default.
- W3176812541 hasConceptScore W3176812541C126322002 @default.
- W3176812541 hasConceptScore W3176812541C177713679 @default.
- W3176812541 hasConceptScore W3176812541C188816634 @default.
- W3176812541 hasConceptScore W3176812541C2776214593 @default.
- W3176812541 hasConceptScore W3176812541C2776376669 @default.